Codexis (CDXS) to Release Earnings on Wednesday

Codexis (NASDAQ:CDXS - Get Free Report) is anticipated to release its earnings data after the market closes on Wednesday, February 26th. Analysts expect Codexis to post earnings of ($0.04) per share and revenue of $27.41 million for the quarter. Investors interested in registering for the company's conference call can do so using this link.

Codexis Price Performance

NASDAQ CDXS traded up $0.03 during trading hours on Thursday, hitting $4.26. 367,196 shares of the company's stock traded hands, compared to its average volume of 604,794. The company has a market capitalization of $346.68 million, a PE ratio of -4.90 and a beta of 2.12. Codexis has a 52-week low of $2.56 and a 52-week high of $6.08. The firm's 50-day moving average is $4.74 and its 200-day moving average is $3.92. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.21 and a quick ratio of 3.15.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Benchmark restated a "hold" rating on shares of Codexis in a research note on Monday, November 4th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $11.00 price objective on shares of Codexis in a research note on Friday, November 22nd.

Codexis Company Profile

Codexis, Inc discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes.